Key result
In human failing cardiomyocytes, specific PKCα-mediated phosphorylation of the cardiac troponin complex significantly decreased maximal force generation from 26.1 to 17.1 kN/m2 and increased myofilament Ca2+-sensitivity.
Answers are grounded in this paper and cite their sources.
PKCα-mediated phosphorylation of the cTn complex decreases maximal force and alters myofilament Ca2+-sensitivity in human failing cardiomyocytes, highlighting specific phosphorylation targets like Thr143.
AIMS: Protein kinase Cα (PKCα) is one of the predominant PKC isoforms that phosphorylate cardiac troponin. PKCα is implicated in heart failure and serves as a potential therapeutic target, however, the exact consequences for contractile function in human myocardium are unclear. This study aimed to investigate the effects of PKCα phosphorylation of cardiac troponin (cTn) on myofilament function in human failing cardiomyocytes and to resolve the potential targets involved. METHODS AND RESULTS: Endogenous cTn from permeabilized cardiomyocytes from patients with end-stage idiopathic dilated cardiomyopathy was exchanged (∼69%) with PKCα-treated recombinant human cTn (cTn (DD+PKCα)). This complex has Ser23/24 on cTnI mutated into aspartic acids (D) to rule out in vitro cross-phosphorylation of the PKA sites by PKCα. Isometric force was measured at various [Ca(2+)] after exchange. The maximal force (Fmax) in the cTn (DD+PKCα) group (17.1±1.9 kN/m(2)) was significantly reduced compared to the cTn (DD) group (26.1±1.9 kN/m(2)). Exchange of endogenous cTn with cTn (DD+PKCα) increased Ca(2+)-sensitivity of force (pCa50 = 5.59±0.02) compared to cTn (DD) (pCa50 = 5.51±0.02). In contrast, subsequent PKCα treatment of the cells exchanged with cTn (DD+PKCα) reduced pCa50 to 5.45±0.02. Two PKCα-phosphorylated residues were identified with mass spectrometry: Ser198 on cTnI and Ser179 on cTnT, although phosphorylation of Ser198 is very low. Using mass spectrometry based-multiple reaction monitoring, the extent of phosphorylation of the cTnI sites was quantified before and after treatment with PKCα and showed the highest phosphorylation increase on Thr143. CONCLUSION: PKCα-mediated phosphorylation of the cTn complex decreases Fmax and increases myofilament Ca(2+)-sensitivity, while subsequent treatment with PKCα in situ decreased myofilament Ca(2+)-sensitivity. The known PKC sites as well as two sites which have not been previously linked to PKCα are phosphorylated in human cTn complex treated with PKCα with a high degree of specificity for Thr143.
No takes yet. Share an insight, caveat, or question.
Kooij et al. (2013) studied End-stage idiopathic dilated cardiomyopathy (n=6). PKCα-treated recombinant human cardiac troponin (cTn (DD+PKCα)) exchange vs. Unphosphorylated cTn (DD) exchange was evaluated on Maximal isometric force (Fmax) at saturating Ca2+ concentration (kN/m2) (p=<0.05). In human failing cardiomyocytes, specific PKCα-mediated phosphorylation of the cardiac troponin complex significantly decreased maximal force generation from 26.1 to 17.1 kN/m2 and increased myofilament Ca2+-sensitivity.
Synapse has enriched 10 related papers. Consider them for comparative context: